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Introduction
Until recently genomic study is seen to expand quite rapidly through the ongoing development of science and technologies and today this helps us to uncover many scientific questions and to understand complexities of research problems. In medical research the discovery of genomic markers opens the eyes of scientific community. It is important to identify genomic markers accurately to predict a patients response to the therapies in development. Dasatinib is a novel, oral, multi-targeted kinase inhibitor that is used for the treatment of chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. It has been also used in clinical trials for treating patients with tumors [1] .
To support the clinical development of Dasatinib, Huang et al. sought to identify molecular markers predictive of response to this drug that could be used for patient se-lection during clinical development and beyond [2] . They used three statistical methods to identify the molecular markers: (1) signal to noise ratio (S2N), (2) Pearson correlation coefficients between expression values and another covariate (IC50), and (3) Welch t-statistic. These three statistical methods were used independently to get three lists of genes. Later, the probesets (i.e., variables) that overlapped between these three lists were considered significantly correlated with the Dasatinib sensitivity/resistance classification. Genes are found from these probsets after annotation. However, the use of these three methods may exclude highly variable genes, for which large changes in expression values can fail to enter into the list, thereby eliminating potential important biological information. Figure 1 (a) presents the variances corresponding to the treatment effect (i.e. absolute mean) for the expression values of cell lines (i.e., samples) where the data is taken from the Gene Expression Omnibus (GEO) [2] . It appears that few of the probsets have low variability with high treatment effects which cause S2N or t-statistic high and increases the chance of selecting false positive genes. Figure 1 (b) also confirms the presence of a number of probsets which have high variances compared to the mean (i.e., coefficient of variation in denominator). Again, correlation coefficients are highly affected by these highly variable expression values. Moreover, Huang et al. did not consider the correlation among the probsets instead they considered correlation coefficient between a single gene expression values and the values of IC50. These limitations in the analysis by Huang et al. motivate us to apply alternative approaches to prioritize genes based on three popular statistical methods and a method of sparse principal component analysis (PCA).
The statistical methods used to detect differentially expressed genes (DEGs) can be classified into two broad categories: parametric and nonparametric methods. The most commonly used parametric methods are the two-sample t-test and its variations which are based on Wald statistics. Tusher et al. proposed a method called significance analysis of microarray (SAM) for detecting DEGs [3] . Smyth suggested the moderated t-statistic, which generalized the sample standard deviation and are found to be robust against outliers [4, 5] . The moderated t-statistic is available in the R package LIMMA and the SAM is available in the R package siggenes. Alternatively, Hossain and Beyene considered skewed distribution instead of assuming normal distribution for expression data to identify the genomic markers [6] . All statistical tests were corrected for multiple hypotheses by using the Benjamini-Hochberg method to determine the false discovery rate (FDR) [7] . Among nonparametric methods the Wilcoxon rank sum test and area under the receiver operating characteristic curves (AUC) are widely used in gene expression analysis [8] [9] [10] . In this paper, we applied three popular methods of LIMMA, SAM and AUC.
Principal Component Analysis (PCA) is a multivariate dimension reduction and visualization technique that produces a new set of variables called principal components (PCs), constructed as linear combinations of the original variables. The limitation of PCA is that PCs are comprised of all original variables, which is unrealistic in highdimensional genomic data and confusing, since the interpretation of PCs near impossible with large number of genomic markers. A new extension to classical PCA, sparse principal component Analysis (Sparse PCA), that systematically forces all original variables with residual contribution to have 0-valued loadings, therefore attaining a more concise and realistic group structure of the data, and a more interpretable set of PCs for further analysis [11, 12] . Hastie et al. proposed the popular gene shaving techniques using PCA to cluster highly variable and coherent genes in microarray datasets [13] . The lasso is a promising variable selection technique, simultaneously producing accurate and sparse models [14] . Zou and Hastie proposed the elastic net, a generalization of the lasso, which has some advantages [15] . In this paper, we applied the Sparse PCA using elastic net to summarize a gene expression profile of breast cancer cell lines (sparse PCs) for a subset of the data.
Data and Methods

The data
The data is obtained from Gene Expression Omnibus (GEO), accessible through GEO series accession number GSE6569. The data contains expression of 22283 probsets (i.e., variables). Twenty-three breast cancer cell lines (i.e., samples) were used to identify candidate markers that may predict response to Dasatinib. There were 7 of them are sensitive to the drug and 16 are resistant to the drug. Thus, the matrix to be analyzed has 22283 rows of probsets and 23 columns of conditions corresponding to each sample. Details about the dataset can be found in the paper of Huang et al. [2] . They proposed a list of 161 genes that can be used to classify patients with sensitive and resistant to the drug Dasatinib. Starting with the 22283 probsets collected from GEO, we filtered out the bottom 75 percent in terms of Inter-Quartile Range (IQR), retaining only the 5571 most variable probsets. We removed probsets that have very little variation to begin with, since they won't provide much chance for difference detection anyway. We transformed all gene expression values using log base 2 to achieve distributions closer to normal.
Statistical Methods
We used three commonly used methods to identify differentially expressed genes and later we applied sparse PCA method. Perhaps uncovering an underlying genetic structure in terms of variances and correlations with a Sparse PCA method will allow for a more concise analysis. The methods are descibed briefly as follows:
t-test and its variation
The simplest method to detect differential gene expression is by ranking based on the fold change (FC) or ratio in expression means between the two conditions. A widely used alternative method is a t-test. The t-test is very close to signal to noise ratio that was used in the Huang et al. paper. Because of the large number of genes included in this experiment, there are some genes with a very small variances across cell lines (Figure 1 ), so that their t-values are large regardless of whether or not the differences in their averages are large. These turn out to be false positives for the t-statistic. Several alternative statistics have been proposed to overcome this problem, and many of them are influenced by the theory of shrinking the variance [3, 4, 7] . In this paper, we statistically tested marginal associations between each probset and the sensitivity/resistance to the drug Dasatinib by using moderated-t statistics (LIMMA) and SAM method. We took top 400 ranked probsets after adjusting for false-discovery rate (FDR). Huang et al. also considered top 400 genes considering p-values at 1% significance level. Moderated-t statistics, p-values, and FDR-adjusted p-values were calculated using the LIMMA package in R v3.26.0 [16] . SAM statistic was calculated by using siggenes Bioconductor package [17] .
Area under Receiver Operating Characteristic Curve
Troyanskaya et al. applied the Wilcoxon rank sum test (RST) to gene expression analysis [24] . The RST is a nonparametric alternative to the two-sample t-test which is based solely on the rank of the expression values in which the observations from the two groups fall. An assessment of the expression of a gene can be made through the use of a receiver operating characteristic (ROC) curve. The ROC approach allows us considering the agreement between expression values and the presence of different thresholds simultaneously. Pepe et al. argue that two measures related to the ROC curve are suitable for ranking genes in regards to DE between two conditions: the Area under the ROC curve (AUC) and the partial AUC (pAUC) [8] . The AUC can be interpreted as the probability that a randomly selected subject from treatment group has greater expression values than a randomly selected subject from control group. For continuous genomic data, the nonparametric ROC curve may be preferred since it passes through all observed points and provides unbiased estimates of sensitivity, specificity, and AUC in large samples [9] . We calculated the nonparametric AUC for the expression data by using the R package WLpAUC downloaded from SIGMA website (http://beyene-sigma-lab.com/). We considered the top 400 probsets considering AUC values greater than 0.81.
Sparse principal components analysis
Principal components analysis (PCA) is a popular dimension reduction technique for determining the key variables in a multidimensional data set that explains the differences in the observations, and can be used to simplify the analysis as well as visualization of multidimensional data sets [18, 19] . The main focus of PCA is to investigate data patterns through the variance-covariance structure. The only downfall from a regression standpoint is the interpretation. For a particular PC (linear combination), the loadings The application of PCA to a genomic data doesn't allow summarizing the ways in which gene expressions vary under two biological conditions. The variance accounted for by each of the components is its associated eigen value; it is the variance of a component over all genes. Consequently, the eigenvectors with large eigen values are the ones that contain most of the information; eigen vectors with small eigen values are uninformative [19] . PCA suffers from the fact that each principal component is a linear combination of all the original variables, thus it is often difficult to interpret the results. In this circumstance we apply the sparse PCA using the lasso (or elastic net) to produce modified principal components with sparse loadings [12, 15] .
Results
We apply the SAM, moderated-t statistic (LIMMA), and AUC and get 3 different lists of top ranked 400 probsets. After having gene annotation of these probsets we get the Concordance genes are those which are commonly found in the gene lists by the methods. In attempt to visualize some block-structure, we use a clustering algorithm to align these genes as would be needed to draw a dendrogram [21, 22] . We apply the hierarchical clustering technique to predict the sensitive/resistance of the Dasatinib and it is presented as a heatmap in Figure 3 . It appears that the 28 genes can separate the samples clearly though 4 of the cell lines are misclassified. The heatmap shows patterns of color where the cell lines and genes are associated and therefore attempt to accomplish one of the missions Sparse PCA sets out to do; find natural groupings of genes. Moving to joint associations of genes, we build 6 sparse PCs from the correlation matrix of the Dasatinib data by using the sparse PCA method. The "spca()" function in the R-package elasticnet was used to get the 6 sparse PCs [15] . We defined the number of sparse loadings to be obtained as 22, 22, 22, 12, 12 and 12 for the 6 sparse PCs respectively. These numbers are approximately found after testing the penalty parameters. Therefore, we found 22 non-zero loadings in the first sparse principal component and 12 non-zero loadings in the 6th sparse principal component. The non-zero elements of the loading vectors are presented in Table 1 . Of the first 6 sparse PCs we investigate, the total percentage of genes variance explained by first PC is 11.2%. This is a substantial amount considering almost 96.5% of the loadings were forced to 0, validating the ability of sparse PCA as a dimension reduction technique. As one can see, the genes from SPC1 comprise a tightly-packed, high-variance group and the probsets from SPC2 and SPC3 comprise groups of lesser variance. It would now be convenient for researchers to use these SPCs to try and detect differences between sensitivity/resistent group of Dasatinib. In this regard, we fitted logistic models to the list of genes that are found in each of SPCs and estimated the prediction of a probability of a "success" (here, resistant group samples are being in case or success group). Though fitting the logistic regression model with 22 genes and 23 cell lines is a bad idea because of over-fitting problem, we did it to get an idea of comparing SPCs. These models are evaluated by receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC) is calculated for each of the 6 SPCs. The results of AUC is not shown here because of over-fitting results, but we found first sparse PCs (SPC1) provide better discrimination between the resistant /sensitivity of Dasatinib after investigating the AUC values. We found 7 concordance genes with the list of 28 genes comparing the gene list of SPC1. We suggest using these 22 genes from SPC1 because of the strength of relationship among them. Therefore we suggest a total of 43 genes, which are listed in highlight potential blocks of variables, the same image strategy by a heatmap in Figure 4 is used on the sample correlation matrix and a more intensifying color scale is attempted. Though the cluster analysis is not enough to validate the results, it is necesasry to do a validation with other cell lines. It is often more beneficial to narrow down only a few genetic variants to aid researchers in further exploration; in this regard we give a very concise list of 43 genes. In addition, we presented an analysis plan in Figure 5 . The analytical procedures that applied in the study to get the 43 genes can also be used as a guideline to analyze other similar type of genomic data. SPC1  SPC2  SPC3  SPC4  SPC5  SPC6  1 ABCA3  CCDC102B PCCA  GPR20  PARD6B  JAG1  2 LAMB3  TPD52  IL15RA  ELOVL2 IGF1R  BAMBI  3 F2RL1  ITGA5  CADM1  FRY  KCNK15  PTPN21  4 PLCB4  VAMP5  ANXA6  TAS2R13 GSDMB  SLC16A5  5 PTRF  KRT81  SCCPDH  KRT7  PDE4A  HLA-DQB1  6 TNFRSF21 NR2F2  CTAG2  CACNB4 ARIH2  MAOA  7 FXYD5  VGLL1  DNAJC28  DDX43  PDE4DIP  EGR2  8 STRN3  ENO2  MMRN1  KIR3DL1 IL13RA2  ZNF37BP 
Discussion and Conclusion
Statistical genomics is a field to convert the high-dimensional data into knowledge. It is often more beneficial to narrow down only a few genetic variants to aid researchers in further exploration. The Sparse PCA method provides a new insightful way to detect important features of the data using correlation among genes into account. The study demonstrates the results of sparse PCA that helps identifying a new set of genes compared the results of Huang et al. We proposed a gene list that involves only a few genes, so researchers can focus on these specific genes for further analysis. The analysis helps determining which genes have changed significantly in terms of their expression between sensitivity and resistant of the Dasatinib drug. To deliver small subsets of genes, we take advantage of the computational efficiency of the three popular marginal methods and a sparse principal component analysis. The analysis also reveals classification of important groups and their associations within genes. Overall, the results have given us a better understanding in classifying groups of genomic markers that are associated with sensitivity/ resistant of Dasatinib for the breast cancer patients. However, the paper presented as a research proposal of the genomic markers that are correlated with sensitivity in solid tumors in Dasatinib and clinical applications are pending of future research. This research is motivated by the belief that the Sparse PCA method might lead to robust results in taking correlation among genes with the Dasatinib breast cancer cell lines data since correlation among genes are very common. We discussed the steps to use the Sparse PCA method as well as other commonly used methods to identify the differntially expressed genomic markers. Therefore, in this study we provide a new set of genes that may have more biological relevance. We anticipate that the present study will help adding scientific knowledge in medical research especially the use of the drug Dasatinib to cancer patients by taking consideration of the new set of gene list. In addition, the analytical procedures that applied in the study can also be a useful guideline to analyze other similar type of genomic data.
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